Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MBD5 mRNA | decreases expression | 19933214
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MBD5 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of MBD5 mRNA | affects expression | 20382639
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in decreased expression of MBD5 mRNA | affects cotreatment|decreases expression | 17891453
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MBD5 mRNA | decreases expression | 19933214
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in decreased expression of MBD5 mRNA | affects cotreatment|decreases expression | 17891453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.84 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.84 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.84 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.93 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.93 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.93 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 16354765 15668235 12621046 15340226 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 16714409 15322242 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
15.83 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
15.83 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.57 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.57 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
4.02 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.69 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.93 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.93 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 12621046 15340226 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.40 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.99 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.21 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.33 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.43 | 17679729 19010910 18460780 18206229 18704418 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.43 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.98 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.66 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.66 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.25 | 20464547 17053015 18816296 6695378 18569708 18520028 20135361 20064080 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.25 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.64 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.86 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.86 | 16505122 |
OMIM:156200 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 1 |
marker/mechanism |
|
| |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
8.39 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
8.39 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.54 | 18608210 16882708 19157545 19010910 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.56 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.56 | 19116145 19470736 17925555 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.54 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.54 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.99 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.99 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11222880 11118676 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.86 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.86 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.39 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.39 | 18798265 19789329 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.75 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.90 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.90 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.52 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.52 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.57 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.47 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.47 | 17616700 19087683 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.43 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |